CRISPR Therapeutics
BioTech/Drugs - Boston, Massachusetts, US
CRISPR Therapeutics Employees
Rabiah Choudhary
Manager, Global Pharmacovigilance & Risk Management Operations
CRISPR Therapeutics Senior Management
CRISPR Therapeutics Details
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom.
CRISPR Therapeutics Technologies
Email Providers
Outlook
CMS
Drupal
Other
Microsoft Office 365
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud